Khasiat
daun Ganja
Cannabis has been used in research to treat conditions including
diabetes, Parkinson’s disease, epilepsy, myeloma, psoriasis, fibromyalgia,
PTSD, cancer, multiple sclerosis (MS), chronic pain, and broken bones.
marijuana’s molecular structure can be modified to tailor cannabinoids
to specific receptors for treating symptoms.
Hebrew University researchers synthesized 22 versions of the cannabinoid
THC that have great potential for treating neurological and inflammatory diseases.
“Cannabis should be considered, so far as possible, in the same manner
as any other medicinal product, requiring supervision and regulation in order
to protect public health and welfare, even when taking into account its special
characteristics — being a plant rather than a product manufactured in a
laboratory or factory,” according to the Health Ministry’s Medical Cannabis Unit.
OWC Pharmaceutical Research, a developer of cannabinoid-based therapies
targeting a variety of different indications, and Breath of Life Pharma, which
provides cannabis-based medical products and cannabinoid APIs (active
pharmaceutical ingredients), are working with the Health Ministry,
universities, medical institutions and researchers to develop cannabis-based pharmaceuticals
and treatments.
Kalytera Therapeutics, a US company developing a new class of
proprietary cannabidiol (CBD) therapeutics, recently licensed two synthetic
cannabis derivatives from the Hebrew University’s technology transfer company
Yissum, for eventual use in treating osteoporosis, bone fractures and other
diseases.
Medical cannabis is increasingly being used for a variety of
indications, such as reducing nausea during chemotherapy and relieving pain and
muscle spasticity in multiple sclerosis patients. Development of state-of-the
art delivery systems for the active ingredients will undoubtedly pave the way
for a wider variety of clinical indications for these types of drugs.
No comments:
Post a Comment
Note: only a member of this blog may post a comment.